EUVIMEDEUVIMED entdecken
Crossref

Rethinking the amyloid dogma in Alzheimer’s disease

George Perry

The Biomedical & Life Sciences Collection · 31.03.2026 · 2026 (3) · e1008434

DOI: 10.69645/tpjr7660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Biomedical & Life Sciences Collection, online erschienen am 31.03.2026. Verfasst von George Perry.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Perry, G. (2026). Rethinking the amyloid dogma in Alzheimer’s disease. The Biomedical & Life Sciences Collection, 2026(3), e1008434. https://doi.org/10.69645/tpjr7660

Vancouver

Perry G. Rethinking the amyloid dogma in Alzheimer’s disease. The Biomedical & Life Sciences Collection. 2026;2026(3):e1008434. doi:10.69645/tpjr7660

BibTeX
@article{Perry2026,
  author = {Perry, George},
  title = {Rethinking the amyloid dogma in Alzheimer’s disease},
  journal = {The Biomedical & Life Sciences Collection},
  year = {2026},
  volume = {2026},
  number = {3},
  pages = {e1008434},
  doi = {10.69645/tpjr7660}
}
Kostenlos starten →